| |
|
|
| Home»Publications/Presentations |
Publications/Presentations
Below is a list of YHEC publications and presentations. To search please use the Search option above or contact us with any query. click the  icon to view the full record, or click the linked text in the reference to go to the published record.
Click here to scroll down to our presentations
Publications:
Brush J, Boyd K, Chapell F, Crawford F, Dozier M, Fenwick E, Glanville JM, McIntosh H, Renehan A, Weller D, Dunlop M. The Value of FDG Positron Emission Tomography/Computerised Tomography (PET/CT) in Pre-Operative Staging of Colorectal Cancer: A Systematic Review and Economic Evaluation Health Technology Assessment 2011; 15: 1-191. Glanville, J, Kendrick A, McNally R, Campbell J, Hobbs FD. Research output on primary care in Australia, Canada, Germany, the Netherlands, the United Kingdom, and the United States: bibliometric analysis. BMJ 2011; 342: d1028. Bending MW, Trueman P, Lowson KV, Pilgrim H, Tappenden P, Chilcott J & Tappenden J.. Estimating the direct costs of bowel cancer services provided by the National Health Service in England International Journal of Technology Assessment in Health Care 2010; 26(4): 362-369. Glanville J and Paisley S. Evidence based economics Searching for evidence on resource use, costs, effects and cost-effectiveness In: Shemilt I et al editors. Oxford: Wiley-Blackwell 2010. Hex, Nick. The role of boards In: Edinburgh: Audit Scotland 2010 September. Available from: The role of boards Hutton, J. Mixed palette Pharmaceutical Marketing Update 2010; July/August : 24-26. Lenoir-Wijnkoop I, Dapoigny M, Dubois D, van Ganse E, Gutiérrez-Ibarluzea I, Hutton J, Jones P, Mittendorf T, Poley MJ, Salminen S, Nuijten MJC. Nutrition economics - characterising the economic and health impact of nutrition British Journal of Nutrition 2010; 1-9. Brown A, Craig J. Oxford Diabetes Library: Heart Disease and Diabetes Health economics of treating heart disease in diabetes In: Fisher M editors. Oxford: OUP 2009. Stamuli E, Kruger J, Hutton J. Cost-effectiveness of ultrasound elastography in the assessment of liver fibrosis Centre for Evidence-Based Purchasing Economic Report CEP08053 2009; February. Bending MW, Beale S, Hutton J. An economic analysis of workplace interventions that promote physical activity PHIAC Report, National Institute for Health and Clinical Excellence 2008; April. Hex, Nick. Day surgery in Scotland In: Edinburgh: Audit Scotland 2008 September. Available from: Day surgery in Scotland Lefebvre C, Manheimer E, Glanville J, on behalf of the Cochrane Information Retrieval Methods Group. Cochrane Handbook for Systematic Reviews of Interventions Chapter 6: Searching for studies In: Higgins JPT, Green S editors. Chichester, UK: The Cochrane Collaboration and John Wiley & Sons, Ltd 200895-150. Muszbek N, Thompson MM, Soong CV, Hutton J, Brasseur P, van Sambeek MRHM. Systematic review of utilities in abdominal aortic aneurysm European Journal of Vascular and Endovascular Surgery 2008; 36(3): 283-289. Nic Lochlainn E, Abbotts J, Craig J, Downie S, Eastgate J, Kohli H, Macpherson K, McIntosh H, Riches E, Thompson J, Twaddle S, Wilson S. Service delivery organisation for acute low back pain (HTA programme systematic review 1) In: Edinburgh: NHS Quality Improvement Scotland 2008 Available from: Service delivery organisation for acute low back pain (HTA programme systematic review 1) Beale S, Bending MW, Hutton J. A rapid review of economic literature: workplace health promotion - how to encourage employees to be physically active PHIAC Report, National Institute for Health and Clinical Excellence 2007; August. Beale S, Bending MW, Trueman P. An economic analysis of environmental interventions that promote physical activity PDG Report, National Institute for Health and Clinical Excellence 2007; April. Beale S, Bending MW, Yi Y, Trueman P. A rapid review of economic literature related to environmental interventions that increase physical activity levels in the general population PDG Report, National Institute for Health and Clinical Excellence 2007; March. Lowson K, Young J, Green J, Forster A, Small N, Bogle S, George J, Heseltine D, Jayasuriya T, Rowe J. Post acute care for older people in community hospitals: a multicenter randomized, controlled trial Journal of the American Geriatrics Society 2007; 55(12): 1995-2002. Ritchie K, Bradbury I, Craig J, Eastgate J, Foster L, Kohli H, Iqbal K, MacPherson K, McCarthy T, McIntosh H, Nic Lochlainn E, Reid M, Taylor J. The clinical and cost effectiveness of screening for meticillin-resistant staphylococcus aureus (MRSA) (HTA report 9) In: Edinburgh: NHS Quality Improvement Scotland 2007 Available from: The clinical and cost effectiveness of screening for meticillin-resistant staphylococcus aureus (MRSA) (HTA report 9) Brown P, Brunnhuber K, Chalkidou K, Chalmers I, Clarke M, Fenton M, Forbes C, Glanville J, Hicks NJ, Moody J, Twaddle S, Timimi H, Young P. How to formulate research recommendations BMJ 2006; 333: 804-6. Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, Orlewska E, Tam T, Trueman P, Watkins J, Wilson A. Principles of good practice for budget impact analysis Report of the ISPOR Task Force on Good Research Practices - Budget Impact Analysis 2006; September. Téot L, Cherry G, Denis C, Dervaux B, Duncan G, Gottrup F, Harding K, Kerihuel JC, Lautenberg A, Mani R, Meaume S, Messina R, Morris S, Orsted H, Pavlovic M, Peter R, Ricci E, Sibbald G, Sussmann G, Trueman P, World Union of Wound Healing Societies. Reimbursement of dressings: a WUWHS statement International Wound Journal 2006; 3(4) December: 296-301. Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy Health Technology Assessment 2006; 10(34): 1-222. Hutton J. Health policy and economics Discussion of chapter 3: eliciting equity-efficiency trade-offs in health In: Smith PC, Ginnelly L, Sculpher M editors. Maidenhead: Open University Press 2005. Spencer A, Chilton SM, Covey J, Taylor MJ. Testing the internal consistency of the lottery equivalent method using health outcomes: a comment to Oliver Health Economics 2005; 14: 161-167. Craig, J, Bradbury I, Collinson P, Emslie C, Findlay I, Hunt K, Kohli H, Kulkarni U, Macpherson K, Riches E, Single A, Tochel C. The organisation of troponin testing services in acute coronary syndromes (HTA report 4) In: Edinburgh: NHS Quality Improvement Scotland 2004 Available from: The organisation of troponin testing services in acute coronary syndromes (HTA report 4) Sheldon TA, Cullum N, Dawson D, Lankshear A, Lowson KV, Watt I, West PA, Wright DL, Wright J. What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients; notes, and interviews BMJ 2004; 329: 999. Bagust A, Schoeffski O, Shearer A, Goertz A, Reitberger U, Behrens M. The DiDACT economic model of type 2 diabetes for Germany Diabetes und Stoffwechsel 2003; 12(Suppl 1): 159. Bagust A, Shearer A, Schoeffski O, Reitberger U, Goertz A, Behrens M. Cost-effectiveness in Germany of rosiglitazone-metformin combination in type 2 diabetes Diabetologia 2003; 46(Suppl 2): A444. Gordois A, Scuffham PA, Shearer A, Oglesby A. The costs and consequences of peripheral neuropathy in the UK The Diabetic Foot 2003; 6(1): 30-37. Gordois A, Scuffham PA, Shearer A, Oglesby A. The health care costs of diabetic nephropathy in the United Kingdom and the United States Diabetes 2003; 52(Suppl 1): A185-186. Misso K, Glanville J. Evidence-based Oncology Finding the best evidence for cancer care In: Williams C, Bramwell V Bonfill X, Cuzick J, Forbes J, Grant R, Guthrie D, Mason M, Simmonds P, Singh A D, Weston R, Williams H editors. London: BMJ Books 2003. Sanderson DJ, Limber C, Eldred C, Harrison K. To the ENT degree Health Service Journal 2003; 113(5844) 27 February: 26-27. Slattery J, Chick J, Cochrane M, Craig J, Godfrey C, Kohli H, Macpherson K, Parrott S, Quinn S, Single A, Tochel C, Watson H. Prevention of relapse in alcohol dependence In: Edinburgh: NHS Quality Improvement Scotland 2003 Available from: Prevention of relapse in alcohol dependence Glanville J, Haines M, Auston I. Getting research findings into practice Sources of information on clinical effectiveness and methods of dissemination In: Haines A, Donald A editors. London: BMJ Publications 2002. Glanville J, Wright K. Guide to internet resources for health technology assessment Evaluated research evidence and evidence collections In: Auston, I editors. Bethesda: National Library of Medicine 2002. Scuffham PA, Taylor MJ. Economics and decisions to end life: van Acht and Stooker revisited Applied Health Economics and Health Policy 2002; 1(3): 123-128. Taylor MJ. Scuffham PA. New Zealand bicycle helmet law: do the costs outweigh the benefits? Injury Prevention 2002; 8: 317-320. Glanville J. A guide to healthcare resources on the Internet Health statistics on the web In: Kiley R editors. London: Royal Society of Medicine Press 2001. Droogan J, Glanville J, Watt I, Wilson P. Access to the evidence base from general practice in Northern and Yorkshire Region: report to NHSE Northern & Yorkshire Region York: NHS Centre for Reviews and Dissemination 2000. Glanville J. Clinical research in psychiatry: a practical guide Carrying out the literature search In: Curren S, Williams CJ editors. Oxford: Butterworth-Heinemann 1999. Hittinger R, Glanville J, Cartwright J, Johnson S, Gregson D. Clinical governance: making it happen Guide to sources In: Lugon M, Secker-Walker J editors. London: Royal Society of Medicine 1999. Glanville J, Haines M, Auston I. The implementation of research findings Sources of information on clinical effectiveness and methods of dissemination In: Haines A, Donald A editors. London: BMJ Publications 1998. Craig, J. Economic appraisal of dabigatran etexilate 150 mg compared to warfarin or aspirin in patients with atrial fibrillation In: West Yorkshire Cardiac Network
Presentations:
Craig JA, Saxby RC. Economic Evaluation of HeartWare LVAS in the Support of End-Stage Heart Failure in the UK ISPOR 14th Annual European Congress, Madrid, 2011 Glanville JM, Duffy SB and McCool R. Clinical Trial Registers as a Source of Trials for Cochrane Reviews Cochrane Colloquium (October 2011) 2011 Taylor M, Lewis L, Lebmeier M, Wang Q. An Economic Evaluation of Dasatinib for the Treatment of Imatinib Resistant Patients with Advanced Phase Chronic Myelogenous Leukaemia ISPOR 16th Annual International Meeting (May 21-25, 2011) Baltimore, MD, USA 2011 Taylor M, Lewis L, Lebmeier M, Wang Q. An Economic Evaluation of Dasatinib for the Treatment of Imatinib Resistant Patients with Chronic Myelognous Leukaemia ISPOR 16th Annual International Meeting (May 21-25, 2011) Baltimore, MD, USA 2011 Beale S, Tatlock S, Wheeler K, Ryan J. Telehealth – initial users’ views and impact on healthcare resource use ISPOR, Prague (November 2010) 2010 Beale SJ, Tatlock SR, Wheeler K, Ryan J. Telehealth - Initial Users' Views and Impact on Healthcare Resource Use ISPOR 13th Annual European Congress, Prague, 2010 2010 Beale S, Cardow T, Trueman P, Land M. Is RA care meeting the needs of patients in England? Key findings from a patient survey Rheumatology ''09 (April 2009) 2009 Beale S, Hutton J, Kruger J. Pressures faced by people who care for somebody diagnosed with a cardiovascular condition European ISPOR Conference, Paris (2009) 2009 Juarez-Garcia A, Uc-Coyoc R, Hernandez-Rivera G, Rangel S, Taylor MJ, Litalien G, Donato B. The cost and cost effectiveness of dasatinib (sprycel) 100mg therapy for the management of imatinib resistant and intolerant patients in chronic phase with chronic myeloid leukemia (CML) in Mexico Latin America ISPOR Conference, Rio de Janiero, Brazil (2009) 2009 Taylor MJ. The economics of vaccine interventions European ISPOR Conference, Paris (2009) 2009 Taylor MJ, Righetti C, Conway P, Lebmeier M. Capturing treatment effectiveness in the modelling of rheumatoid arthritis: a methodological approach European League against Rheumatism Conference, Copenhagen, Denmark (2009) 2009 Taylor MJ, Saxby R. International preferences for health care systems: a discrete choice experiment approach. Health Economics, Management and Policy Conference, Athens, Greece (2009) 2009 Taylor MJ, Saxby RC. Early modelling: methods in the economic analysis of pre-phase II products European ISPOR Conference, Paris (2009) 2009 Whitehead SJ, Taylor MJ, Christensen J, Bech PG. An economic evaluation of Grazax for the treatment of grass pollen induced rhino conjunctivitis in children International ISPOR Conference, Orlando, Florida, USA (2009) 2009 Bending MWB, Hutton J, McGrath C, Kruger J. Analysis of Factors Associated with Reimbursement Decision Making in Health Technology Assessment Agencies ISPOR 11th Annual European Congress, Athens (November 2008) 2008 Craig J, Aguiar-Ibanez R, Downie S, Duffy S, Nimmo A, Trueman P, Wilson S, Yunni Y. The clinical and cost effectiveness of thromboelastography/throboelastometry compared with standard lab tests and clinical discretion 9th Annual Symposium for the Network for Advancement of Transfusion Alternatives (NATA), Lisbon (April 3-4 2008) 2008 Craig J, Trueman P. Turning evidence based guidelines into practice - can resource impact analyses help? Priorities in Healthcare, Gateshead (October 28-31 2008) 2008 Dolezal T, Skoupa J, Taylor MJ, Whitehead SJ, Pavlikova P, Rausova V. Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes in the Czech Republic ISPOR European Conference, Athens, Greece (2008) 2008 Taylor MJ, Ganderton M, Conway P, Lebmeier M. The cost-effectiveness of sequential use of anti-tumor necrosis factor agents in the treatment of rheumatoid arthritis ISPOR European Conference, Athens, Greece (2008) 2008 Taylor MJ, Saxby R, Conway P, Lebmeier M. The economic implications of achieving treatment response in patients with rheumatoid arthritis ISPOR European Conference, Athens, Greece (2008) 2008 Taylor MJ, Saxby R, Ganderton M, Conway P, Lebmeier M, Packham J. The relationship between health assessment questionnaire score and resource use in the management of rheumatoid arthritis European League against Rheumatism Annual Conference, Paris (June 2008) 2008 Taylor MJ, Whitehead SJ, Chilton S. Accounting for initial disease severity when measuring health gains 72nd Health Economics Study Group Meeting, University of East Anglia (January 2008) 2008 Trueman P. A comparative analysis of the economics of obesity interventions Royal College of General Practitioners Annual Meeting, Bournemouth (October 2-4 2008) 2008 Trueman P. Cost effectiveness of VAC therapy in the home health setting World Union of Wound Healing Societies (June 4-7 2008) 2008 Trueman P. Relative cost effectiveness of different weight loss/weight maintenance programmes National Obesity Forum Annual Meeting (October 7 2008) 2008 Trueman P, Hurry MV, Bending MW, Hutton J. Comparative analysis of health technology assessments of drug eluting stents HTAi Annual Meeting, Montreal (July 5 -9 2008) 2008 Alastair Fischer, Paul Trueman, Lesley Owen, Pelham Barton. Background quit rates in smoking cessation HTAi Annual Conference, Barcelona (June 2007) 2007 Brosa M, Taylor MJ, Staginnus U et al. Cost-effectiveness of dasatinib vs imatinib 800 mg/day in patients with imatinib-resistant chronic myeloid leukaemia in Spain ISPOR European Conference, Dublin (October 2007) 2007 Flack SM, Apelqvist J; Trueman P; Keith M S; Williams D. The cost-effectiveness of Vacuum Assisted Closure® (VAC) therapy for the treatment of diabetic foot wound ISPOR 12th International Conference, Arlington, VA, USA (May 2007) 2007 Glanville J, Lefebvre C. Progress towards a ''one-stop-shop'' for critically-appraised methodological search filters in the context of systematic reviews: the InterTASC Information Specialists'' Sub-Group Search Filters Resource Evidence Based Library and Information Practice Conference (EBLIP4), Chapel Hill, North Carolina (May 6-9 2007) 2007 Glanville J, Ritchie G, Lefebvre C. Do published search filters to identify diagnostic test accuracy studies perform adequately? Health Technology Assessment International (HTAi) IV Annual Meeting, Barcelona (June 2007) 2007 Glanville J, Whiting P, Westwood M, Burke M, Sterne J. Which databases should we search to identify diagnostic test accuracy studies? Health Technology Assessment International (HTAi) IV Annual Meeting, Barcelona (June 2007) 2007 Joyeux A, Taylor MJ et al. Cost-effectiveness analysis in Canada of dasatinib versus imatinib for the treatment of chronic myelogenous leukaemia in patients with imatinib resistance American Society of Hematology (ASH), Atlanta (December 2007) 2007 Keith MS, Flack SM, Apelqvist J, Trueman P, Williams D. The cost-effectiveness of Vacuum Assisted® Closure (VAC®) therapy for the treatment of diabetic foot wounds Diabetic Foot Global Conference, Los Angeles, CA, USA (March 2007) 2007 Logman JFS, Taylor MJ, Neumann K, et al. Cost-utility of dasatinib (Sprycel®) in patients after first-line failure of imatinib in chronic myeloid leukemia in Austria ISPOR European Conference, Dublin (October 2007) 2007 Taylor MJ. Accounting for initial disease severity when measuring the benefits of health gains ISPOR European Conference, Dublin (October 2007) 2007 Taylor MJ. Accounting for initial health status in measuring the benefits of health care technologies ISPOR European Conference, Dublin (October 2007) 2007 Taylor MJ. The relationship between short-term response and long-term outcomes in the treatment of chronic myelogenous leukaemia ISPOR 12th International Conference, Arlington, VA, USA (May 2007) 2007 Taylor MJ, Chaplin S, Goldsmith D, Maloney D, Elgazzar H. An international economic evaluation of sevelamer hydrochloride versus calcium-based phosphate binders in patients new to dialysis ISPOR European Conference, Dublin (October 2007) 2007 Taylor MJ, Chaplin S, Goldsmith D, Maloney D, Elgazzar H. An international economic evaluation of sevelamer hydrochloride versus calcium-based phosphate binders in patients new to dialysis Conference of the American Society of Nephrologists, San Francisco (November 2007) 2007 Taylor MJ, Cisse S. Using discrete choice experiment methods to elicit public preferences towards international health systems ISPOR European Conference, Dublin (October 2007) 2007 Taylor MJ, Ganderton M, Trueman P, Reynolds A, Conway P. A comparison of the lifetime cost-effectiveness of etanercept versus abatacept following anti-TNF treatment in patients with rheumatoid arthritis American College of Rheumatology, Boston (November 2007) 2007 Taylor MJ, Ganderton M, Trueman P, Reynolds A, Conway P. Lifetime health benefits and costs of etanercept compared against abatacept following failure Of methotrexate American College of Rheumatology, Boston (November 2007) 2007 Taylor MJ, Minda K. An economic evaluation of dasatinib for the treatment of imatinib-resistant patients with chronic myelogenous leukaemia ISPOR European Conference, Dublin (October 2007) 2007 Taylor MJ, Minda K, Ray S et al. Economic evaluation of dasatinib (Sprycel ®) as a treatment for chronic phase chronic myeloid leukaemia in Scotland ISPOR European Conference, Dublin (October 2007) 2007 Taylor MJ, Trueman P, Reynolds A, Conway P. Costs and benefits of etanercept followed by rituximab at different stages of the treatment sequence in patients with rheumatoid arthritis British Society of Rheumatology, Birmingham (2007) 2007 Taylor MJ, Trueman P, Reynolds A, Conway P. Economic benefits of etanercept following anti-TNF treatment in patients with rheumatoid arthritis: an analysis using TEMPO data British Society of Rheumatology, Birmingham (2007) 2007 Trueman P, Flack SM, Loonstra A, Hauser T. The early use of VAC® therapy is associated with an increased probability of achieving predefined treatment goals in patients with surgical wounds EWMA Glasgow (May 2-4 2007) 2007 Trueman P, Flack SM, Loonstra A, Hauser T. Treatment characteristics and clinical outcomes of VAC® therapy in patients with surgical wounds - a retrospective analysis EWMA Glasgow (May 2-4 2007) 2007 Ulrich R, Simmonds M, Young P, Buisseret A, Howells A, Warren W, Millman J, Hastie D, Hametz I, Place B, Bending MW. The estate we're in: symposium on single bed ward accommodation Symposium on single bed ward accommodation, Cardiff (June 2007) 2007 Beale SJ, Bagust A, Home PD, Mendes da Costa S, Ganderton M, Shearer A. The cost-effectiveness of rosiglitazone for the treatment of type 2 diabetes in the UK using different methods to model clinical effects 19th World Diabetes Congress, Cape Town (December 2006) 2006 Ganderton M, Bagust A, Liebl A, Mendes da Costa S, Shearer A. Impact on disease progression and health outcomes associated with different methods of modelling the clinical effect of rosiglitazone in Germany 19th World Diabetes Congress, Cape Town (December 2006) 2006 Glanville J, Lefebvre C. How to identify randomized controlled trials in MEDLINE: ten years on Health Technology Assessment International (HTAi) Annual Conference, Adelaide (July 2006) 2006 Glanville J, Lefebvre C, Golder S, Myers L, Stirk L. The InterTASC Information Specialists'' Sub-Group''s Search Filter Resource: progress to date and plans for the future Health Technology Assessment International (HTAi) Annual Conference, Adelaide (July 2006) 2006 Shearer A, Bagust A, Ampudia-Blasco FJ, Taylor MJ, Mendes da Costa S. The impact of improved beta-cell function on modelling the cost-effectiveness of Rosiglitazone in the management of type 2 diabetes in Spain ISPOR 9th European Congress, Copenhagen (October 2006) 2006 Shearer A, Bagust A, Ampudia-Blasco FJ, Taylor MJ, Mendes da Costa S. The impact of improved beta-cell function on modelling the cost-effectiveness of rosiglitazone in the management of type 2 diabetes in Spain 19th World Diabetes Congress, Cape Town (December 2006) 2006 Taylor MJ, Bagust A, Pereira JA, Mendes da Costa S, Beale SJ, Shearer A. The cost-effectiveness of rosiglitazone for treatment of type 2 diabetes in Portugal using different methods to model clinical effects ISPOR 9th European Congress, Copenhagen (October 2006) 2006 Taylor MJ, Bagust A, Pereira JA, Mendes da Costa S, Beale SJ, Shearer A. Modelling coronary heart disease experience and time to insulin in a Portuguese population treated with rosiglitazone: the impact of improved beta-cell function 19th World Diabetes Congress, Cape Town (December 2006) 2006 Taylor MJ, Chaplin S, Trueman P, Posnett J, Searle R. Economic evaluation of the use of exogen for fresh fracture of the tibia in patients at risk of non-union ISPOR 9th European Congress, Copenhagen (October 2006) 2006 Taylor MJ, Trueman P, Chaplin S. Exogen for the improved healing of tibial fractures ISPOR European Conference, Copenhagen, Denmark (2006) 2006 Trueman P, Flack S. Economic evaluation of Weight Watchers in the prevention and management of obesity Clinical Excellence, Birmingham (December 2006) 2006 Twena N, Taylor MJ, Trueman P, Chubb B. Assessing the economic burden of needlestick injuries associated with insulin delivery amongst healthcare professionals in community settings in the United Kingdom European Association for the Study of Diabetes Annual Conference. Copenhagen, Denmark and Malmo, Sweden (2006) 2006 Taylor M, Trueman P et al. Economic benefits of achieving clinical and radiologic remission with etanercept in patients with rheumatoid arthritis American College of Rheumatology Annual Meeting, San Diego (November 2005) 2005 Taylor MJ, Redmond SM, Chaplin S, Duffy SB, West PA. Systematic review on relapse and antipsychotic non-adherence in schizophrenia ISPOR International Conference, Washington DC, USA (May 2005) 2005 Taylor MJ, Scuffham PA, McCollam P, Newby D. Acute coronary syndromes in Europe: one-year costs and outcomes ISPOR International Conference, Washington DC, USA (May 2005) 2005 Taylor MJ, Trueman P, Conway P, Reynolds A, Pearce D. Economic benefits of achieving clinical and radiographic remission with etanercept in patients with rheumatoid arthritis: an analysis using TEMPO data American College of Rheumatology Conference, San Diego, CA (October 2005) 2005 Trueman P. The burden of pressure ulcers to the NHS and the potential impact of VAC therapy Wounds UK, Harrogate (November 2005) 2005 . Cost-effectiveness of meal replacement products in weight control European Congress on Obesity, Prague (May 26-29 2004) 2004 . Economic evaluation of community hospital care for older people British Geriatric Society, Harrogate (October 6-8 2004) 2004 Drummond M, Nixon J, Boulenger S, Ulmann P, Glanville J, de Pouvourville G. The European Network of Health Economic Evaluation Databases (EURO NHEED) project First Hull-York Medical School Research Conference, Hull (February 2004) 2004 Glanville J. One experience of bridging health and social science research: the DARE database 12th Cochrane Colloquium, Ottawa (October 2004) 2004 Glanville J. Optimal search for the evidence in oncology How to practice evidence based oncology conference, Antwerp (July 2004) 2004 Glanville J, Boynton J, Lefebvre C. Literature searching for systematic reviews and health technology assessments (HTAs): can one rule fit all? Health Technology Assessment International (HTAi) Annual Conference, Krakow (May 2004) 2004 Glanville J, Golder S, Ginnelly L. Database searching for information to populate decision-analytic models: a case study Health Technology Assessment International (HTAi) Annual Conference, Krakow (May 2004) 2004 Glanville J, Lefebvre C, Camosso-Stefinovic J, Miles J. Finding RCTs becomes easier Health Technology Assessment International (HTAi) Annual Conference, Krakow (May 2004) 2004 Glanville J, Lefebvre C, Miles J, Camosso-Stefinovic J. Finding RCTs on MEDLINE: a search filter for busy researchers Health Libraries Group Conference, Belfast (September 2004) 2004 Glanville J, Orton V, Starr M, Timimi H. Developing access to research evidence: the rebirth of RefeR Health Libraries Group Conference, Belfast (September 2004) 2004 Nixon J, Duffy S, Armstrong N, Craig D, Glanville J, Christie J, Drummond M, Kleijnen J. Improving outcomes through access to critiqued economic evaluations: the NHS Economic Evaluation Database within the HTA review process First Hull-York Medical School Research Conference, Hull (February 2004) 2004 Beale SJ, Bagust A, Richter A, Thieda P, Perry AS. A cost-effectiveness evaluation of adding rosiglitazone versus sulphonylurea to metformin in a US obese type 2 diabetes population 18th International Diabetes Federation Congress, Paris (August 24-29 2003) 2003 Glanville J, Nixon J, Duffy SB, Craig D, Armstrong N, Christie J, Drummond MF, Kleijnen J. Improving outcomes through access to critiqued economic evaluations: the NHS Economic Evaluation Database within the HTA review process ISTAHC Conference, Canmore, Canada (June 2003) 2003 Nixon J, Duffy S, Armstrong N, Craig D, Glanville J, Christie J, Drummond M, Kleijnen J. Improving outcomes through access to critiqued economic evaluations: the NHS Economic Evaluation Database within the HTA review process NICE conference, Birmingham (December 2003) 2003 Bagust A, Beale SJ, Downs KE, Stewart M. Pattern of long-term beta-cell function deterioration in type 2 diabetes European Association for the Study of Diabetes 38th Annual Meeting, Budapest (September 1-5 2002) 2002 Glanville J, Bagnall AM, Jones L, Kleijnen J. Assessing adverse events in a systematic review of atypical antipsychotics for schizophrenia Systematic Reviews Symposium, Oxford (July 2002) 2002 Glanville J. Evidence based search strategy design: identifying systematic reviews in MEDLINE 9th Cochrane Colloquium, Lyon (October 2001) 2001 Glanville J, Lefebvre C, White V, Sheldon T. Evidence-based search strategy design: identifying systematic reviews in MEDLINE Evidence Based Librarianship Conference, Sheffield (September 2001) 2001 Light K, Glanville J, Booth A, Golder S, Richardson R, Watt I. Cochrane library user group: a blueprint for local feedback initiatives? 9th Cochrane Colloquium, Lyon (October 2001) 2001
|
| |
|
 |
|
|
|
